KEY POINTS

  • Products affected by the recall include Pedialyte and certain Similac products
  • They were distributed in the U.S. and other countries including Canada
  • Parents who find that they have a recalled product should not use them

Abbott is voluntarily recalling specific lots of certain ready-to-feed liquid products because of a "potential for spoilage." Certain Similac products are included in the recall.

The problem with the recalled products is that some of them (less than 1%) have bottle caps that "may not have sealed completely," according to the company announcement on the U.S. Food and Drug Administration (FDA) website. This may then lead to spoilage.

"If spoiled product is consumed, gastrointestinal symptoms such as diarrhea and vomiting may occur," Abbott noted.

This recall affects several products, including Pedialyte Electrolyte Solution and various Similac products that were produced in Abbott's facility in Columbus, Ohio. They were "distributed primarily to hospitals, doctor's offices, distributors, and some retailers" in the U.S., while some lots were also distributed in Puerto Rico, Canada, Colombia, the Dominican Republic and some Caribbean countries.

"It's important to note that not all recalled products were distributed in all countries and not all 2 fl oz/59 ml formulas are included in the recall," Abbott added.

In the U.S., for instance, the recall affects certain lots of "Similac 360 Total Care, Similac 360 Total Care Sensitive, Similac Special Care 24, Similac Pro-Total Comfort, Similac NeoSure, Pedialyte Electrolyte Solution." While in Panama, the recall affects two lots of Similac Pro-Total Comfort.

A full list of the affected products in specific countries as well as the affected bottle lot numbers can be found here. The list also includes photos of the products' packaging, including where the lot numbers may be located.

The recall does not affect other liquid or powder formula products manufactured at the Columbus facility, according to the company. Furthermore, the issuance does not affect the U.S. infant formula supply.

Parents and caregivers who may have an affected product are being advised not to use them. Consumers with questions about the recall may call +1-800-986-8540 if they are in the U.S. or +1-787-622-5454 if they are in Puerto Rico. The numbers to call for other affected countries including Curacao, Canada, Haiti and St. Croix are available on the FDA and company websites.

"Ensuring the quality of our products and the safety of our consumers is our top priority, and a responsibility we take very seriously, including taking action when a product doesn't meet our quality standards," Abbott noted.

Abbott Laboratories logo is displayed on a screen at the New York Stock Exchange (NYSE) in New York City, U.S., October 18, 2021.
Abbott Laboratories logo is displayed on a screen at the New York Stock Exchange (NYSE) in New York City, U.S., October 18, 2021. Reuters / BRENDAN MCDERMID